Found 447 articles for: "General Medical Dermatology"
Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert Opinion
November 2026 | Volume 25 | Issue 11 | Original Article | 1019 | Copyright © November 2026
Background: Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease characterized by greasy, scaly plaques on the scalp or body, often with pruritus and impaired ...
Read MoreImmunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy
November 2026 | Volume 25 | Issue 11 | Original Article | 1045 | Copyright © November 2026
Background: The use of immunosuppressive and immunomodulatory medications in dermatology remains challenging in patients with active or prior malignancy due to concerns of cancer...
Read MoreBruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials
November 2026 | Volume 25 | Issue 11 | Original Article | 1039 | Copyright © November 2026
Background: Systemic lupus erythematosus (SLE) is a chronic relapsing autoimmune disease with frequent cutaneous involvement and unmet treatment need. Given safety and efficacy c...
Read MoreImpetigo Antibiotic Stewardship and the Need for Treatment Alternatives
November 2026 | Volume 25 | Issue 11 | Original Article | 1003 | Copyright © November 2026
Background: Impetigo is a highly contagious bacterial skin infection, primarily caused by Staphylococcus aureus and, less frequently, Streptococcus pyogenes. Although typically s...
Read MoreBiomarkers and Clinical Disease Severity in Hidradenitis Suppurativa: A Linear Mixed-Effects Modeling Study
November 2026 | Volume 25 | Issue 11 | Editorials | e96 | Copyright © November 2026
Beyond the Brain: Understanding the Dermatologic Associations of Neurodegenerative Diseases
November 2026 | Volume 25 | Issue 11 | Features | 1080 | Copyright © November 2026
Off-Label Uses of Nemolizumab: A Narrative Review
October 2026 | Volume 25 | Issue 10 | Original Article | 956 | Copyright © October 2026
Background: Nemolizumab, a humanized monoclonal antibody targeting interleukin-31 receptor α (IL-31Rα), is approved for atopic dermatitis (AD) and prurigo nodularis (...
Read MoreA Narrative Review of Seven Off-Label Treatment Options for Seborrheic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 943 | Copyright © October 2026
Background: Seborrheic dermatitis (SD) is a chronic inflammatory skin condition driven by overactive sebaceous glands, Malassezia colonization, immune dysfunction, and epidermal ...
Read MoreAssociation Between Sodium-Glucose Cotransporter-2 Inhibitors and Vulvar Pruritus Without Vulvovaginal Candidiasis: A TriNetX-Based Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e89 | Copyright © October 2026
Cardamonin Inhibits Keloid Fibroblast Activation and Extracellular Matrix Production Through Suppression of TGF-β1/Smad Signaling
September 2026 | Volume 25 | Issue 9 | Original Article | 857 | Copyright © September 2026
Background: Keloids are pathological scars characterized by persistent fibroblast activation and excessive extracellular matrix (ECM) deposition. Cardamonin (CARD), a natural cha...
Read MoreJAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study
September 2026 | Volume 25 | Issue 9 | Original Article | 779 | Copyright © September 2026
Background: Keloids and hypertrophic scars are fibroproliferative skin disorders characterized by excessive collagen deposition and high recurrence rates despite existing therapi...
Read MoreEyebrow Madarosis: An Updated Review of the Etiology and Management, Part II– Scarring Disorders
September 2026 | Volume 25 | Issue 9 | Original Article | 852 | Copyright © September 2026
Background: Eyebrows play an essential role in facial symmetry, communication, and aesthetic identity. Scarring eyebrow alopecia results from inflammatory, autoimmune, infectious...
Read MoreGLP-1 Receptor Agonist Paradox in Hair Biology: A Biphasic dWAT–Follicle Signaling Hypothesis
September 2026 | Volume 25 | Issue 9 | Features | 874 | Copyright © September 2026
Systemic Corticosteroids in the Perioperative Setting for Prevention of Pyoderma Gangrenosum During Reconstructive Surgery
September 2026 | Volume 25 | Issue 9 | Case Reports | 865 | Copyright © September 2026
Pyoderma gangrenosum (PG) is classified as a neutrophilic dermatosis, often presenting as a rapidly enlarging ulcer and associated with inflammatory bowel disease, specifically ulcerative colitis...
Read MoreTopical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report
September 2026 | Volume 25 | Issue 9 | Case Reports | 868 | Copyright © September 2026
Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder characterized by persistent, violaceous, reticulated skin changes that may be complicated by painful ulcera...
Read MoreReview of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia
September 2026 | Volume 25 | Issue 9 | Features | 871 | Copyright © September 2026
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
August 2026 | Volume 25 | Issue 8 | Original Article | 701 | Copyright © August 2026
Background: Papulopustular rosacea (PPR) is a chronic inflammatory facial dermatosis with a need for well-tolerated and effective topical therapies. Clascoterone cream 1% is an a...
Read MoreMolluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
August 2026 | Volume 25 | Issue 8 | Original Article | 717 | Copyright © August 2026
Background: Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substa...
Read MoreImprovement of Rosacea With Tirzepatide: A Case Report
August 2026 | Volume 25 | Issue 8 | Case Reports | 749 | Copyright © August 2026
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum
August 2026 | Volume 25 | Issue 8 | Features | e71 | Copyright © August 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
